SCHEMBL6516

SCHEMBL6516

CCOC(=O)C1(c2ccc(-c3ccc(-c4onc(C)c4CN(C)C4CCCCC4)cc3)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 1/20 0.47
SLCO1B1 Q9Y6L6 2/20 0.43
TRPV1 Q8NER1 2/20 0.38
HRH4 Q9H3N8 1/20 0.38
HRH3 Q9Y5N1 1/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ABCC3 O15438 1/20 0.37
ABCC4 O15439 1/20 0.37
ABCB11 O95342 1/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2C9 P11712 1/20 0.37
ABCB4 P21439 1/20 0.37
LPAR1 Q92633 1/20 0.37
ABCC2 Q92887 1/20 0.37
SLCO1B3 Q9NPD5 1/20 0.37
OPRM1 P35372 6/20 0.37
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6894 0.95 SLC6A9 (0.41) SLC6A9SLCO1B1TRPV1TSHRLMNA
SCHEMBL7767 0.90 SLC6A9 (0.49) SLC6A9SLCO1B1TRPV1HRH4HRH3
SCHEMBL6825 0.84 LPAR1 (0.48) SLC6A9SLCO1B1TRPV1ABCC3ABCC4
SCHEMBL6517 0.83 SLC6A9 (0.40) SLC6A9SLCO1B1TRPV1TSHRLMNA
SCHEMBL2635538 0.83 SLC6A9 (0.40) SLC6A9SLCO1B1ABCC3ABCC4ABCB11
SCHEMBL5044 0.83 SLCO1B1 (0.41) SLC6A9SLCO1B1TSHRLMNANPSR1
SCHEMBL6226 0.82 OPRM1 (0.44) SLCO1B1TSHRLMNANPSR1TDP1
SCHEMBL1147 0.82 OPRM1 (0.44) SLCO1B1TSHRLMNANPSR1TDP1
SCHEMBL2636805 0.81 SLCO1B1 (0.38) SLC6A9SLCO1B1TSHRLMNANPSR1
SCHEMBL950 0.81 OPRM1 (0.43) SLCO1B1TSHRLMNANPSR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483252-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS Amira Pharmaceuticals, Inc. (US) 2012-08-08 EP disclosed
WO-2011041694-A2 COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed